A detailed history of Cetera Investment Advisers transactions in Medtronic PLC stock. As of the latest transaction made, Cetera Investment Advisers holds 338,830 shares of MDT stock, worth $28.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
338,830
Previous 381,585 11.2%
Holding current value
$28.5 Million
Previous $30 Million 1.56%
% of portfolio
0.07%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.84 - $91.03 $3.29 Million - $3.89 Million
-42,755 Reduced 11.2%
338,830 $30.5 Million
Q2 2024

Aug 22, 2024

SELL
$78.71 - $87.02 $2.02 Million - $2.23 Million
-25,667 Reduced 6.3%
381,585 $30 Million
Q1 2024

May 24, 2024

BUY
$82.84 - $88.09 $27.8 Million - $29.6 Million
336,083 Added 472.23%
407,252 $35.5 Million
Q1 2024

May 14, 2024

SELL
$82.84 - $88.09 $2.53 Million - $2.69 Million
-30,547 Reduced 30.03%
71,169 $6.2 Million
Q4 2023

Feb 13, 2024

SELL
$69.43 - $83.43 $1.66 Million - $1.99 Million
-23,845 Reduced 18.99%
101,716 $8.38 Million
Q3 2023

Nov 14, 2023

SELL
$78.22 - $90.4 $617,155 - $713,256
-7,890 Reduced 5.91%
125,561 $9.84 Million
Q2 2023

Aug 09, 2023

BUY
$79.47 - $91.38 $428,184 - $492,355
5,388 Added 4.21%
133,451 $11.8 Million
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $1.01 Million - $1.15 Million
13,111 Added 11.41%
128,063 $10.3 Million
Q4 2022

Feb 14, 2023

BUY
$76.18 - $87.74 $3.72 Million - $4.28 Million
48,807 Added 73.79%
114,952 $8.94 Million
Q3 2022

Nov 10, 2022

SELL
$80.75 - $95.31 $475,375 - $561,089
-5,887 Reduced 8.17%
66,145 $5.34 Million
Q2 2022

Aug 11, 2022

BUY
$87.4 - $113.09 $681,195 - $881,423
7,794 Added 12.13%
72,032 $6.47 Million
Q1 2022

May 13, 2022

BUY
$100.58 - $112.38 $1.17 Million - $1.31 Million
11,619 Added 22.08%
64,238 $7.13 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $756,925 - $971,538
7,605 Added 16.89%
52,619 $5.44 Million
Q3 2021

Nov 16, 2021

BUY
$122.75 - $135.17 $212,603 - $234,114
1,732 Added 4.0%
45,014 $5.64 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $337,905 - $375,958
2,859 Added 7.07%
43,282 $5.37 Million
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $31,575 - $34,006
-284 Reduced 0.7%
40,423 $4.78 Million
Q4 2020

Feb 17, 2021

BUY
$100.57 - $117.14 $2.29 Million - $2.67 Million
22,814 Added 127.5%
40,707 $4.77 Million
Q3 2020

Nov 13, 2020

SELL
$90.13 - $108.78 $326,540 - $394,109
-3,623 Reduced 16.84%
17,893 $1.86 Million
Q2 2020

Aug 13, 2020

SELL
$84.11 - $103.33 $4,962 - $6,096
-59 Reduced 0.27%
21,516 $1.97 Million
Q1 2020

May 08, 2020

BUY
$72.92 - $121.3 $248,219 - $412,905
3,404 Added 18.73%
21,575 $1.95 Million
Q4 2019

Feb 10, 2020

BUY
$104.49 - $114.54 $170,632 - $187,043
1,633 Added 9.87%
18,171 $2.06 Million
Q3 2019

Nov 06, 2019

BUY
$98.02 - $111.18 $211,233 - $239,592
2,155 Added 14.98%
16,538 $1.8 Million
Q2 2019

Aug 12, 2019

BUY
$84.15 - $99.38 $198,509 - $234,437
2,359 Added 19.62%
14,383 $1.4 Million
Q1 2019

May 06, 2019

SELL
$82.45 - $93.79 $7,173 - $8,159
-87 Reduced 0.72%
12,024 $1.1 Million
Q4 2018

Feb 15, 2019

SELL
$85.8 - $99.49 $39,982 - $46,362
-466 Reduced 3.71%
12,111 $1.1 Million
Q3 2018

Nov 14, 2018

BUY
$85.91 - $99.17 $842,777 - $972,857
9,810 Added 354.54%
12,577 $1.24 Million
Q2 2018

Aug 14, 2018

BUY
$77.48 - $87.83 $542 - $614
7 Added 0.25%
2,767 $237,000
Q1 2018

May 09, 2018

BUY
$76.55 - $87.26 $4,133 - $4,712
54 Added 2.0%
2,760 $221,000
Q4 2017

Feb 08, 2018

SELL
$76.93 - $83.5 $3,769 - $4,091
-49 Reduced 1.78%
2,706 $217,000
Q3 2017

Nov 16, 2017

SELL
$77.71 - $84.6 $148,503 - $161,670
-1,911 Reduced 40.96%
2,755 $214,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,666
4,666 $414,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $112B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.